Clinical Trial

A Study to Evaluate the Safety, Pharmacokinetics of AD-118 and AD-1181 in Healthy Adult Subjects

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
A Study to Evaluate the Safety and Pharmacokinetics of AD-118 and AD-1181 Under Fasted Conditions in Healthy Adult Subjects
Trial Details
NCT Number NCT07717749
Lead Sponsor Addpharma Inc.
Conditions Chronic Heart Failure
Enrollment 74 participants
Start Date 2026-07-24
Primary Completion 2026-08 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2026-07-21